Blog

Welcome to our blog! Explore educational content ranging from innovative treatments to insightful medical knowledge, curated by Dr. Rezaian, a specialist in Rheumatology and Internal Medicine.

Understanding Rheumatoid Arthritis: Symptoms, Treatments, and Living with RA

Understanding Rheumatoid Arthritis: Symptoms, Treatments, and Living with RA

The presentation of RA typically involves symmetric joint pain, stiffness, and swelling, most commonly affecting the hands, wrists, and feet. The stiffness is often worse in the morning or after periods of inactivity, lasting for more than thirty minutes. RA can also...

read more

Joint Ventures: Exploring the Many Faces of Arthritis

Joint Ventures: Exploring the Many Faces of Arthritis

Arthritis is a common condition characterized by inflammation of one or more joints, leading to pain, swelling, stiffness, and reduced range of motion. It affects millions of people worldwide and can significantly impact quality of life. There are several types of...

read more

Unlocking Relief: Bimekizumab’s Impact on Psoriatic and Spondyloarthritis

Unlocking Relief: Bimekizumab’s Impact on Psoriatic and Spondyloarthritis

Bimekizumab, a novel biologic therapy, is showing promising results in the treatment of psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis (nr-axSpA, M46.80). This medication belongs to a class of drugs known as monoclonal...

read more

Optimizing Immunity: Strategic Timing of COVID-19 Booster for Patients on Biologic Therapy

Optimizing Immunity: Strategic Timing of COVID-19 Booster for Patients on Biologic Therapy

The American College of Rheumatology (ACR) has provided guidance on the timing of COVID-19 booster vaccinations for patients undergoing biologic therapy. These recommendations are essential for ensuring that patients with rheumatic diseases, who are often on...

read more

Cybersecurity Breach at Change Healthcare: Navigating the Impact on Access to Otezla and Enbrel

Cybersecurity Breach at Change Healthcare: Navigating the Impact on Access to Otezla and Enbrel

The Cybersecurity Incident at Change Healthcare Change Healthcare, a prominent player in the U.S. insurance claim processing sector, has experienced a cybersecurity breach, leading to significant disruptions in provider and pharmacy operations. This has affected the...

read more

“Enhanced Protection: The Case for COVID-19 Boosters with Biologics”

“Enhanced Protection: The Case for COVID-19 Boosters with Biologics”

The American College of Rheumatology (ACR) has issued recommendations regarding the use of COVID-19 booster vaccines for patients undergoing biologic therapy, a treatment often prescribed for various autoimmune conditions, such as rheumatoid arthritis, psoriatic...

read more

Understanding Your Bone Density Results: A Guide for Everyone

Understanding Your Bone Density Results: A Guide for Everyone

When it comes to maintaining our health, bones play a crucial role, acting as the framework of our body, protecting organs, anchoring muscles, and storing calcium. A bone density test, or DEXA scan, is a way to measure the strength and density of your bones. It’s like...

read more

Rheumatic Medications: A New Frontier in Alzheimer’s Prevention?

Rheumatic Medications: A New Frontier in Alzheimer’s Prevention?

Recent studies have hinted at the intriguing possibility that certain drugs used in the treatment of rheumatic diseases might also have beneficial effects in preventing or delaying the development of Alzheimer’s disease. This article delves into the emerging...

read more

Rinvoq: Truly Remarkable. The most proximate semblance to normality.

Rinvoq: Truly Remarkable. The most proximate semblance to normality.

Rinvoq, a newer medication in the field of rheumatology and immunology, has shown remarkable efficacy in managing several chronic inflammatory conditions. As a selective Janus kinase (JAK) inhibitor, Rinvoq specifically targets pathways that contribute to the...

read more

Xeljanz: Performance undeminished by Adaptation

Xeljanz: Performance undeminished by Adaptation

Xeljanz, known generically as tofacitinib, is a medication that represents a significant advancement in the treatment of various autoimmune diseases. Approved by the FDA, Xeljanz operates by inhibiting Janus kinase (JAK) pathways, which are crucial in the process of...

read more

Meet The Author

M M Rezaian, MD

M M Rezaian, MD

Rheumatology

Dr. Rezaian, who has dedicated over thirty years to the practice of Rheumatology, focuses on the utilization of biologic therapies for treating rheumatic diseases, the study of Spondyloarthropathy, and the innovative field of Telemedicine. He is connected with the WVU Berkeley Medical Center in Martinsburg, West Virginia.

Categories